merck glp-1 drug Drugs: 6 Things We've Learned About Their Effects Merck Enters into Exclusive Global
Description
101 Albiglutide Albiglutide was approved by the FDA in 2014
For example, Meissner et al133 conducted a randomized controlled trial evaluating lixisenatide in patients with early stage PD receiving standard treatment
Intervention Studies evaluating GLP-1 receptor agonists (Liraglutide, Lixisenatide, Semaglutide, Exenatide, Albiglutide, Dulaglutide, Efpeglenatide)
Glucose Control: They prevent the liver from releasing too much excess sugar into the bloodstream
Verma S, McMurray JJV
